Vimarsana
Biggest News Aggregation in the World

Technology Anmat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Anmat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Anmat Today - Breaking & Trending Today

'I felt pains all over my body': Argentina battles dengue outbreak as politicians pass up vaccine opportunity | Dengue fever - Vimarsana News

'I felt pains all over my body': Argentina battles dengue outbreak as politicians pass up vaccine opportunity | Dengue fever

Rising temperatures, dense urban populations and increasing poverty have contributed to more than a quarter of a million cases, and campaigners don’t think the government is doing enough about it

Dengue vaccine available in Argentina - Vimarsana News

Dengue vaccine available in Argentina

Argentine health authorities Thursday announced that the Japanese-developed TAK-003 vaccine against dengue was already available in the South American country at a cost of AR$ 37,500 (around US$ 38, at the unofficial “blue” rate).

No prescription required in Argentina for "morning-after pill" — MercoPress - Vimarsana News

No prescription required in Argentina for "morning-after pill" — MercoPress

Argentina's Health Ministry issued a resolution allowing for the emergency hormonal contraception method (AHE), also known as 'the morning-after pill' to be sold in all pharmacies nationwide without a medical prescription. This measure, published in Thursday's edition of the Official Gazette, also includes an update of the protocol for the comprehensive care of persons entitled to the voluntary and legal termination of pregnancy.

Argentina to receive bivalent Covid-19 vaccines in first quarter of 2023 - Vimarsana News

Argentina to receive bivalent Covid-19 vaccines in first quarter of 2023

Argentina's Health Ministry Carla Vizzotti insisted that people needed to get an additional shot of Covid-19 vaccine if the last application was over 120 days ago, regardless of the number of doses taken previously, and announced the country would have bivalent vaccines available in the first quarter of 2023.

More funding for Argentine-developed Covid-19 booster jab - Vimarsana News

More funding for Argentine-developed Covid-19 booster jab

Argentina's National Agency for the Promotion of Research, Technological Development and Innovation (Agencia I+D+i) granted funding worth AR$ 1.1 billion (around US$ 3.18 million at the unofficial exchange rate) to carry out clinical studies of phases II and III of the 'ARVAC Cecilia Grierson' Covid 19 vaccine, it was reported.